| |
FDA Approval Activities for this Drug
Bravelle (Urofollitropin) Injection Purified, Ferring NDA 21-484 12/19/02 1/30/03 4/9/03 5/8/03
Bravelle (Urofollitropin) Injection Purified, Ferring NDA 21-289 5/6/02 5/9/02 10/9/02
Bravelle Indication: Ovulation Induction UROFOLLITROPIN Intramuscular, Subcutaneous 75 IU/VIAL BRAVELLE FERRING
019415 BX UROFOLLITROPIN Subcutaneous 75 IU/AMP FERTINEX SERONO
For the latest approval information, please see the main page.
|